BG40810A3 - Method for preparing alkaline salts of 4- hydroxy- 2- methyl- n- (2- pyridyl)- 2h- 1, 2- benzothiazine- 3- carboxamide - Google Patents

Method for preparing alkaline salts of 4- hydroxy- 2- methyl- n- (2- pyridyl)- 2h- 1, 2- benzothiazine- 3- carboxamide

Info

Publication number
BG40810A3
BG40810A3 BG065219A BG6521984A BG40810A3 BG 40810 A3 BG40810 A3 BG 40810A3 BG 065219 A BG065219 A BG 065219A BG 6521984 A BG6521984 A BG 6521984A BG 40810 A3 BG40810 A3 BG 40810A3
Authority
BG
Bulgaria
Prior art keywords
piroxicam
solvent
benzothiazine
carboxamide
pyridyl
Prior art date
Application number
BG065219A
Other languages
Bulgarian (bg)
English (en)
Inventor
Melvin Noseworthy
Original Assignee
Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware filed Critical Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware
Publication of BG40810A3 publication Critical patent/BG40810A3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/041,3-Thiazines; Hydrogenated 1,3-thiazines
    • C07D279/081,3-Thiazines; Hydrogenated 1,3-thiazines condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Stabilization Of Oscillater, Synchronisation, Frequency Synthesizers (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
BG065219A 1983-04-25 1984-04-24 Method for preparing alkaline salts of 4- hydroxy- 2- methyl- n- (2- pyridyl)- 2h- 1, 2- benzothiazine- 3- carboxamide BG40810A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48830383A 1983-04-25 1983-04-25

Publications (1)

Publication Number Publication Date
BG40810A3 true BG40810A3 (en) 1987-02-16

Family

ID=23939186

Family Applications (1)

Application Number Title Priority Date Filing Date
BG065219A BG40810A3 (en) 1983-04-25 1984-04-24 Method for preparing alkaline salts of 4- hydroxy- 2- methyl- n- (2- pyridyl)- 2h- 1, 2- benzothiazine- 3- carboxamide

Country Status (28)

Country Link
EP (1) EP0123520B1 (de)
JP (1) JPS59205375A (de)
KR (1) KR840008345A (de)
AT (1) ATE36531T1 (de)
AU (1) AU548451B2 (de)
BG (1) BG40810A3 (de)
CA (1) CA1213220A (de)
CS (1) CS246078B2 (de)
DD (1) DD219672A5 (de)
DE (1) DE3473454D1 (de)
DK (1) DK165168C (de)
EG (1) EG17887A (de)
ES (1) ES531866A0 (de)
FI (1) FI82377C (de)
GR (1) GR81938B (de)
GT (1) GT198404085A (de)
HU (1) HU194217B (de)
IE (1) IE57327B1 (de)
IL (1) IL71598A (de)
MX (1) MX159889A (de)
NO (1) NO165177C (de)
NZ (1) NZ207930A (de)
PH (1) PH18864A (de)
PL (1) PL144064B1 (de)
PT (1) PT78473B (de)
RO (1) RO88420A (de)
YU (1) YU44232B (de)
ZA (1) ZA843013B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582831A (en) * 1984-11-16 1986-04-15 Pfizer Inc. Anti-inflammatory polymorphic monoethanolamine salt of N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide compound, composition, and method of use therefor
HU200926B (en) * 1988-10-28 1990-09-28 Egyt Gyogyszervegyeszeti Gyar Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules
GB9212450D0 (en) * 1992-06-11 1992-07-22 Indena Spa New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
KR100446829B1 (ko) * 2002-02-20 2004-09-04 한국유나이티드제약 주식회사 가용화된 피록시캄을 함유한 확산형 정제의 조성물 및그의 제조방법
KR100791160B1 (ko) * 2006-05-30 2008-01-02 조선대학교산학협력단 멜록시캄의 에탄올아민염 및 이를 함유하는 약제학적조성물
JP2010083826A (ja) * 2008-10-01 2010-04-15 Nihon Generic Co Ltd オキシカム系化合物を含む固形製剤を製造する方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4434164A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts
IN160683B (de) * 1981-06-01 1987-07-25 Pfizer

Also Published As

Publication number Publication date
DK204484D0 (da) 1984-04-24
JPH0251527B2 (de) 1990-11-07
PT78473B (en) 1986-08-28
FI82377C (fi) 1991-03-11
IE57327B1 (en) 1992-07-29
HU194217B (en) 1988-01-28
AU2716084A (en) 1984-11-01
EG17887A (en) 1991-03-30
JPS59205375A (ja) 1984-11-20
IL71598A0 (en) 1984-07-31
MX159889A (es) 1989-09-27
IL71598A (en) 1987-01-30
KR840008345A (ko) 1984-12-14
FI841604A (fi) 1984-10-26
ES8505365A1 (es) 1985-05-16
IE840982L (en) 1984-10-25
NO165177B (no) 1990-10-01
DK165168C (da) 1993-03-08
NO165177C (no) 1991-01-09
EP0123520A1 (de) 1984-10-31
DD219672A5 (de) 1985-03-13
PH18864A (en) 1985-10-21
CA1213220A (en) 1986-10-28
DK204484A (da) 1984-10-26
ATE36531T1 (de) 1988-09-15
ES531866A0 (es) 1985-05-16
EP0123520B1 (de) 1988-08-17
RO88420A (ro) 1986-01-30
FI82377B (fi) 1990-11-30
YU72484A (en) 1988-04-30
GT198404085A (es) 1985-10-16
DK165168B (da) 1992-10-19
PL144064B1 (en) 1988-04-30
NZ207930A (en) 1986-09-10
AU548451B2 (en) 1985-12-12
PT78473A (en) 1984-05-01
FI841604A0 (fi) 1984-04-24
ZA843013B (en) 1985-12-24
CS246078B2 (en) 1986-10-16
HUT34023A (en) 1985-01-28
GR81938B (de) 1984-12-12
YU44232B (en) 1990-04-30
DE3473454D1 (en) 1988-09-22
NO841611L (no) 1984-10-26
PL247378A1 (en) 1985-03-26

Similar Documents

Publication Publication Date Title
ATE133667T1 (de) Thiazolderivate, verfahren zur ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten
NO973646D0 (no) Orale doseringsformer inneholdende et <beta>-laktam antibiotikum
BG40810A3 (en) Method for preparing alkaline salts of 4- hydroxy- 2- methyl- n- (2- pyridyl)- 2h- 1, 2- benzothiazine- 3- carboxamide
ES8403464A1 (es) "procedimiento para la preparacion de (halogeno) alcohil-y -alcoxi-sulfonilureas substituidas con radicales heterocicliclos".
NO304225B1 (no) FremgangsmÕte for fremstilling av kalsiumnitraturea som et granulµrt, fritt-str°mmende fast stoff
ES8605493A1 (es) Un procedimiento para la preparacion de un derivado de acido 2-anilino, 6,1-dihidro-6-oxo-5-pirimidincarboxilico.
JPS52139108A (en) Granulated detergent composition
ES503920A0 (es) Procedimiento de preparacion de mononitratos de 1.4,3.6- dianhidro-hexito sustituidos en 2-0 y 5-0
JPS52113992A (en) Aralkylamine derivatives
DE3160345D1 (en) Alcoxy-propanol amines useful as medicines, and process for their preparation
JPS5283867A (en) Cephalosporins
RO83972B (ro) Procedeu de preparare a derivatilor de oxazafosforine
ES8101570A1 (es) Un procedimiento de preparacion de un monohidrato (forma iii)de n-2-(6-metoxi) benzotiazolil-n'-fenilurea
JPS55124781A (en) 1,4-benzdioxanesulfonamide derivative
JPS52106887A (en) 7-(n-triazinocarbonylamino-alpha-arylacetamido)cephalosporins
JPS5321186A (en) Penicillanic acid derivatives and their preparation
JPS52106888A (en) 7-(n-acylamino-alpha-arylacetamido0-3-azidomethyl acid
SE8405450L (sv) 1,4-dihydropyridinderivat, framstellning derav och farmaceutiska beredningar innehallande dessa
JPS52100440A (en) Optically active alpha-phenylglycine salts with sulfonic acid derivatives
TH5195EX (th) อนุพันธ์พิริดินิลพิริมิดีนชนิดใหม่วิธีการผลิตของสารพวกนั้นและสารป้องกันโรคพืชที่มีสารต่างๆนี้เป็นส่วนเป็นแสดงฤทธิ์
JPS5449332A (en) Remedy for peptic ulcer
JPS57193444A (en) Sulfonate derivative, its preparation and antilipemic agent containing the same
JPS545997A (en) Novel hetrocyclic compounds and process for their preparation
JPS53101336A (en) Cyclooentenedione derivatives, process for their preparation and fungicides for agirculture and horiticulture containing the same
JPS52113944A (en) N-halogenobenzul-n-alkyl-n-phenyl-(thio)-ureas, preparation of the sa me, and method of combatting plant infections by using the same